Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. (references) |
Source: compiled by the editor from various references; see credits. | |
| Subject | Topic | Quote |
Health | It is hoped that this medication, used alone or in conjunction with other antisickling agents, may eventually offer an effective long-term therapy for sickle cell anemia patients. (references) | |
Source: compiled by the editor from ICON Group International, Inc.; see credits. | ||
Hexadecimal (or equivalents, 770AD-1900s) (references)41 4E 54 49 53 49 43 4B 4C 49 4E 47 41 47 45 4E 54 53 |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000001 01001110 01010100 01001001 01010011 01001001 01000011 01001011 01001100 01001001 01001110 01000111 00100000 01000001 01000111 01000101 01001110 01010100 01010011 |
HTML Code (1990) (references)A N T I S I C K L I N G   A G E N T S |
ISO 10646 (1991-1993) (references)0041 004E 0054 0049 0053 0049 0043 004B 004C 0049 004E 0047 0041 0047 0045 004E 0054 0053 |
Encryption (beginner's substitution cypher): (references)3548544353433745464348412354139485453 |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
